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This review explores the proposal that vulnerability to psychological symptoms, particularly
anxiety, originates in constitutional differences in the control of bodily state, exemplified
by a set of conditions that include Joint Hypermobility, Postural Tachycardia Syndrome
and Vasovagal Syncope. Research is revealing how brain-body mechanisms underlie
individual differences in psychophysiological reactivity that can be important for predicting,
stratifying and treating individuals with anxiety disorders and related conditions. One
common constitutional difference is Joint Hypermobility, in which there is an increased
range of joint movement as a result of a variant of collagen. Joint hypermobility is
over-represented in people with anxiety, mood and neurodevelopmental disorders. It
is also linked to stress-sensitive medical conditions such as irritable bowel syndrome,
chronic fatigue syndrome and fibromyalgia. Structural differences in “emotional” brain
regions are reported in hypermobile individuals, and many people with joint hypermobility
manifest autonomic abnormalities, typically Postural Tachycardia Syndrome. Enhanced
heart rate reactivity during postural change and as recently recognized factors causing
vasodilatation (as noted post-prandially, post-exertion and with heat) is characteristic of
Postural Tachycardia Syndrome, and there is a phenomenological overlap with anxiety
disorders, which may be partially accounted for by exaggerated neural reactivity within
ventromedial prefrontal cortex. People who experience Vasovagal Syncope, a heritable
tendency to fainting induced by emotional challenges (and needle/blood phobia), are also
more vulnerable to anxiety disorders. Neuroimaging implicates brainstem differences
in vulnerability to faints, yet the structural integrity of the caudate nucleus appears
important for the control of fainting frequency in relation to parasympathetic tone and
anxiety. Together there is clinical and neuroanatomical evidence to show that common
constitutional differences affecting autonomic responsivity are linked to psychiatric
symptoms, notably anxiety.
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INTRODUCTION
Influential theories argue that bodily states of arousal are a
key component to emotions, and are the basis to emotional
feeling states. Emotional processes are intrinsically coupled to
autonomic bodily responses through shared neural substrates.
Exaggerated patterns of autonomic responsivity can enhance the
expression of panic or anxiety symptoms. Some of the vulnera-
bility to psychological symptoms, particularly anxiety, originates
in constitutional differences in the control of bodily states of
arousal. Joint Hypermobility, Postural Tachycardia Syndrome and
Vasovagal Syncope represent common conditions in which there
is evidently a stronger association. The mechanisms underlying
these brain-body interactions can be defined by combining brain
imaging with detailed physiological monitoring of psychiatric
and neurological patients and healthy controls. Ultimately, these
interactions are relevant to the recognition, understanding and
treatment of individuals with anxiety, and also for stress-sensitive
medical disorders. By characterizing the interplay between brain
and body in detail, clinically relevant insights can be gained into
the mechanisms that underpin both adaptive and maladaptive
psychological and physical states. This in turn will lead to targeted
interventions for the personalized treatment of symptoms, for
enhancing health and resilience and for mitigating adverse events,
e.g., drug side effects. We argue that there are specific yet common
constitutional variants (i.e., phenotypes) in physiological reactiv-
ity (i.e., related to the autonomic nervous system) that have major
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influences on emotional state and by extension on vulnerability
to psychiatric disorder. Below we discuss the relevance of three of
these “neurovisceral phenotypes” (Joint Hypermobility, Postural
Tachycardia Syndrome and Vasovagal Syncope) to psychiatric
symptoms.
NEUROVISCERAL PHENOTYPES
JOINT HYPERMOBILITY
Clinical picture
Joint hypermobility affects up to 20% of the general population
(Mulvey et al., 2013) yet is often poorly recognized (Grahame,
2008). It is characterized by a variation in the type and dis-
tribution pattern of collagen. Autosomal dominant heritance is
often observed, yet few genes are reliably implicated, and a pre-
ponderance amongst females suggests incomplete penetrance,
influenced by sex (see Castori, 2012). Joint hypermobility reflects
a disordered collagen ratio (notably Type I/III) (Child, 1986)
and Joint Hypermobility Syndrome (synonymous with Ehlers-
Danlos Hypermobility Type –formerly Type III) (see, Tinkle et al.,
2009) describes the presence of joint hypermobility with other
musculoskeletal and extra articular connective tissue difficulties
(Grahame et al., 2000). See Table 1 for diagnostic criteria.
Over recent years there has been growing recognition of extra-
articular features of Joint Hypermobility: these affect almost
Table 1 | Diagnostic criteria of JHS/EDS III.
MAJOR CRITERIA
Beighton score of 4/9 or greater (either currently or historically)
Arthralgia for longer than 3 months in 4 or more joints
MINOR CRITERIA
Beighton score of 1, 2 or 3/9 (0, 1, 2 or 3 if aged 50+)
Arthralgia (>3 months) in one to three joints or back pain (>3 months),
spondylosis, spondylolysis/spondylolisthesis
Dislocation/Subluxation in more than one joint, or in one joint on more than
one occasion
Soft tissue rheumatism. > 3 lesions (e.g., epicondylitis, tenosynovitis,
bursitis)
Marfanoid habitus (tall, slim, span/Height ratio >1.03, upper: lower
segment ratio less than 0.89, arachnodactyly [positive Steinberg/Wrist
signs]
Abnormal skin: striae, hyperextensibility, thin skin, papyraceous scarring
Eye signs: drooping eyelids or myopia or antimongoloid slant
Varicose veins or hernia or uterine/rectal prolapse
Joint Hypermobility Syndrome is diagnosed in the presence two major criteria,
or one major and two minor criteria, or four minor criteria. Two minor criteria will
suffice where there is an unequivocally affected first-degree relative.
Joint Hypermobility Syndrome is excluded by presence of Marfan or Ehlers-
Danlos syndromes other than the hypermobility type of Ehlers-Danlos syn-
drome) as defined by the Ghent 1996 and Villefranche 1998 criteria respectively.
Criteria Major 1 and Minor 1 are mutually exclusive as are Major 2 and Minor 2.
every system of the body (unsurprisingly as collagen is not con-
fined to joints). Conditions associated with joint hypermobility
go beyond rheumatology to include Chronic Fatigue Syndrome
(Nijs et al., 2006), Fibromyalgia (Ofluoglu et al., 2006), and
Irritable Bowel Syndrome (Zarate et al., 2010). See Table 2 for
extra-articular disorders associated with joint hypermobility.
Association with psychiatric disorder
Psychiatric phenomena are increasingly recognized as another
important extra-articular manifestation of joint hypermobility.
Bulbena et al. reported the first association between joint
hypermobility and anxiety disorder in rheumatology patients in a
case-control study (Bulbena et al., 1993), the overrepresentation
of hypermobility in anxiety disorder patients was subsequently
confirmed in later studies (e.g., Bulbena et al., 1996; Martin-
Santos et al., 1998). Further studies have consistently demon-
strated this association in non-clinical populations (e.g., Bulbena
et al., 2004a,b) and in a large general population cohort (Bulbena
et al., 2011). This association with anxiety is consistently repli-
cated over the years (Bulbena et al., 1993; Garcia Campayo et al.,
2010; Bulbena et al., 2011; Sanches et al., 2012).
A recent meta-analysis of 3597 subjects demonstrates
consistently that in both healthy and clinical population’s
Table 2 | Summarizes extra-articular disorders associated with joint
hypermobility with example references.
Condition References
Attention deficit hyperactivity disorder Koldas Dogan et al., 2011
Anxiety See later review, e.g.,
(Martin-Santos et al., 1998)
Asthma Morgan et al., 2007
Carpal tunnel syndrome Aktas et al., 2008
Chiari malformation type I Milhorat et al., 2007
Chronic constipation De Kort et al., 2003
Chronic fatigue syndrome Nijs et al., 2006
Chronic regional pain syndrome Stoler and Oaklander, 2006
Crohn’s disease Vounotrypidis et al., 2009
Developmental co-ordination disorder Kirby and Davies, 2007
Fecal incontinence Arunkalaivanan et al., 2009
Fibromyalgia Ofluoglu et al., 2006
Functional gastrointestinal disorder Zarate et al., 2010
Headache attributed to spontaneous
cerebrospinal fluid leakage
Schievink et al., 2004
Hiatus hernia Al-Rawi et al., 2004
Mitral valve prolapse (MVP) Yazici et al., 2004
Migraine Bendik et al., 2011
New daily persistent headache Rozen et al., 2006
Pelvic organ prolapse Lammers et al., 2012
Postural tachycardia syndrome Mathias et al., 2012
Psychological distress Baeza-Velasco et al., 2011
Rectal evacuatory dysfunction Mohammed et al., 2010
Somatosensory amplification Baeza-Velasco et al., 2011
Urinary stress incontinence Karan et al., 2004
Extra-articular disorders associated with joint hypermobility, adapted from
Castori (2012).
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hypermobile people experience significantly more intense fears,
agoraphobia, panic, anxiety, and depressive disorders (Smith
et al., 2014).
Additionally significantly higher rates of joint hypermobil-
ity can be observed among patients with Bipolar Disorder
and Neurodevelopmental disorders, such as Attention Deficit
Hyperactivity Disorder and Autism Spectrum Disorder (Eccles
et al., 2014a,b).
The underlying neurobiological mechanisms associating joint
hypermobility with psychiatric disorders have not been studied in
detail. However, brain and body are intrinsically and dynamically
coupled; perceptions, emotions and cognitions respond to, and
change, the state of the body. These interactions form much
of the content of psychophysiological research identifying bod-
ily signatures of mental activity. The central interaction of
processes supporting the generation and the representation of
autonomically-mediated changes in visceral state may be the
critical mediator of autonomic influences on cognition and emo-
tion. Central viscerosensory and visceromotor representations are
exchanged as afference and efference copies to allow error sig-
naling. Where there is mismatch between intended and actual
autonomic state, corrective efferent reactions are accompanied
by interpretative processes. The unconscious operation of auto-
nomic nervous system can be interrupted by deviations from
expected state, i.e., we become aware of our autonomic bod-
ily state when we experience changes in internal state that are
“unpredicted” by control centers (Seth et al., 2011; Critchley
et al., 2013). In disorders that typically involve impaired colla-
gen (present in blood vessels) such as joint hypermobility and
postural tachycardia syndrome it is likely that reduced venous
return during standing due to venous pooling or denervation
causing low plasma volume may be responsible for a an increased
sympathetic state –as the body attempts to compensate for these
abnormalities—resulting in orthostatic intolerance and associ-
ated symptoms (Bohora, 2010; Benarroch, 2012; Mathias et al.,
2012).
Thus, we postulate that a major factor is the dysregulation
of the autonomic nervous system, which particularly drives the
expression of anxiety, a pervasive symptom across almost all
psychological disorders.
Evidence of autonomic dysfunction in Joint Hypermobility
Significant dysautonomia is observed in patients with Joint
Hypermobility Syndrome. Symptoms related to the auto-
nomic nervous system, such as syncope and presyncope,
orthostatic intolerance, palpitations, chest discomfort, fatigue,
and heat intolerance, are significantly more common among
hypermobile patients. Orthostatic hypotension, postural tachy-
cardia syndrome, and uncategorized orthostatic intolerance
were found in over three-quarters of hypermobile patients
compared to one tenth of controls. Patients with Joint
Hypermobility Syndrome have a greater mean drop in sys-
tolic blood pressure during hyperventilation, and a greater
increase in systolic blood pressure after a cold pressor test,
than controls. They also have evidence of heighted vasoconstric-
tion mediated by alpha-adrenergic and beta-adrenergic hyper-
responsiveness (as assessed by administration of phenylephrine)
as assessed by administration of isoproterenol) (Gazit et al.,
2003).
Symptoms suggestive of autonomic dysfunction are also more
common in patient with Joint hypermobility Syndrome. These
include including presyncope, palpitations and gastrointestinal
disturbances (Hakim and Grahame, 2004). Measures of heart rate
reactivity and reactions to the Valsalva maneuver, during auto-
nomic functional testing also indicate autonomic dysregulation
in Joint Hypermobility Syndrome patients compared to controls,
including (De Wandele et al., 2014).
A recent survey of 361 general psychiatric patients (Eccles
et al., 2014b) demonstrates that symptoms of autonomic dys-
function are not only higher in hypermobile patients, but also
correlate strongly with degree of hypermobility. See Figure 1. This
association is driven further by an effect of gender, such that
there are significant effects in women only. Postural Tachycardia
Syndrome patients report increased dizziness throughout the
menstrual cycle, particularly during menses, compared to healthy
controls (Peggs et al., 2012). Estrogen affects blood volume
(Pritchard, 1965) as well as the renin-angiotensin-aldosterone
system and estrogen therapy has therefore been used to improve
baroreflex regulation in post-menopausal women (Hunt et al.,
2001). Orthostatic intolerance has been found to improve during
themidluteal phase of the menstrual cycle in Postural Tachycardia
Syndrome patients (Fu et al., 2010), this may be due to higher
midluteal estrogen and progesterone levels upregulating renal-
adrenal hormones (Stachenfeld and Taylor, 2005). This may go
some way in explaining the gender differences in orthostatic
symptoms associated with hypermobility. Overall, hypermobile
patients had higher mean autonomic dysfunction and orthostatic
intolerance than non-hypermobile patients. Formal mediation
analysis suggests that orthostatic intolerance partially mediates
the relationship between joint hypermobility and anxiety; again,
an effect only seen in females.
Postural Tachycardia Syndrome is characterized by a marked
rise in heart rate of 30 beats-per-minute or greater occurring
within 10min of head-up tilt or standing from supine, or a
heart rate while upright of >120 beats per minute (Mathias
et al., 2012). Postural Tachycardia Syndrome, in the UK at
least, is very frequently associated with Joint Hypermobility
Syndrome: ninety-six per cent of Postural Tachycardia Syndrome
patients attending a UK tertiary autonomic disorders service
have Joint Hypermobility (Owens et al., in preparation). There
is a strong phenomenological overlap with anxiety disorders:
Patients report symptoms similar to panic, including dizziness,
palpitations and gastrointestinal disturbance. In an examina-
tion of 114 individuals with joint hypermobility syndrome,
over 40% fulfilled criteria for Postural Tachycardia Syndrome
(Hakim et al., 2009). Interestingly, healthy individuals with
hypermobility report increased subjective sensitivity to auto-
nomic bodily changes, a psychological trait that has been asso-
ciated with an increased predisposition to anxiety disorder
(Eccles et al., 2012).
Evidence of brain-body interactions from neuroimaging
Structural differences in key emotion processing brain regions,
notably affecting the amygdala bilaterally, are observed in these
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otherwise healthy individuals. The hypermobile group as a
whole also display decreased anterior cingulate and left pari-
etal cortical volume while the degree of hypermobility correlates
negatively with both superior temporal and inferior parietal
FIGURE 1 | (A) Demonstrates significantly higher total autonomic
dysfunction in hypermobile patients compared to non-hypermobile patients.
(B) Shows significantly higher orthostatic intolerance in hypermobile
patients compared to non-hypermobile patients with an effect of gender.
(C) Demonstrates positive correlation with orthostatic intolerance and
degree of hypermobility with an effect of gender (Eccles et al., 2014b).
volume (Eccles et al., 2012). Figure 2 demonstrates bilateral dif-
ferences in amygdala volume.
In a recent functional neuroimaging study of healthy volun-
teers, hypermobile, compared to non-hypermobile, participants
displayed heightened neural reactivity to sad and angry scenes
within brain regions implicated in anxious feeling states, notably
insular cortex (Mallorqui-Bague et al., 2014).
Conclusions
These data suggest that specific brain regions mediate the interac-
tion between psychological processes and the physiological state
of the body, in a manner ultimately crucial to the generation of
anxiety and related symptoms in the joint hypermobility phe-
notype. The amygdala is a key region supporting motivational
and behaviors and emotional memory; it is implicated in threat
processing, generation of bodily arousal reactions and the expres-
sion of mood symptoms. These neuroimaging data implicate
the amygdala and insular cortices as the most likely neural sub-
strate underlying the association between of hypermobility, clin-
ical anxiety and psychosomatic disorders. Speculatively, potential
mechanisms that may further account for the mediating role of
amygdala between anxiety and hypermobility include heightened
susceptibility to the threat of pain and a perturbation of auto-
nomic afferent feedback (Nicotra et al., 2006). Hypermobility
syndrome is associated with pain syndromes such as fibromyal-
gia, irritable bowel syndrome and chronic regional pain syn-
drome. Differences in amygdala reactivity are also reported for
these (Tracey and Bushnell, 2009). Moreover, there is evidence
to suggest that the autonomic nervous system is dysregulated in
hypermobile individuals. Theoretically, anxiety is linked to the
unpredictable states of bodily arousal, engaging regions such as
amygdala and insula (Paulus and Stein, 2006). Observed differ-
ences in dorsal right anterior cingulate cortex were also observed.
FIGURE 2 | Regions of gray-matter volume difference in hypermobile
participants compared with the non-hypermobile group (threshold
P < 0.001 uncorrected) (Eccles et al., 2012).
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This region is implicated in autonomic reactivity, and engaged in
the cognitive control of pain and negative feeling states (Critchley,
2009; Tracey and Bushnell, 2009).
Hypermobility was also linked to reduced right superior tem-
poral volume. Right superior temporal cortex supports the sen-
sory processing of social emotional information and structural
abnormalities of this region are observed in autism (Boddaert
et al., 2004), where neurodevelopmental emotional deficits are
frequently accompanied by heightened anxiety. Hypermobility
has been linked to autism (Eccles et al., 2014a).
Patients with joint hypermobility show heightened intero-
ceptive sensibility compared to those without (Eccles et al.,
2012) and interoceptive sensitivity has been show to medi-
ate the relationship between state anxiety and hypermobility
and it could be hypothesized combining functional neuroimag-
ing with autonomic monitoring will show that inefficient neu-
ral co-ordination of efferent autonomic drive with imprecise
interoceptive representations may be amplified in hypermobile
individuals.
POSTURAL TACHYCARDIA SYNDROME
Clinical picture and autonomic dysfunction
Postural Tachycardia Syndrome is now recognized as one of the
most common forms of orthostatic intolerance. As noted, it is
characterized by an excessive heart rate increase of +30 beats
per minute (beats per minute) or a heart rate of >120 beats per
minute without orthostatic hypotension within the initial 10min
of orthostasis or head up tilt. Postural Tachycardia Syndrome has
only relatively recently (1993) been clearly described (Schondorf
and Low, 1993) yet reports of soldiers suffering with “irritable
heart syndrome” and “soldier”s heart’—conditions that appear
very similar to Postural Tachycardia Syndrome—date back to the
American Civil War (Wooley, 1976). More recently, it is recog-
nized that symptoms can also be provoked by food digestion,
heat ormoderate exercise in some Postural Tachycardia Syndrome
patients (Mathias et al., 2012).
Postural Tachycardia Syndrome is a heterogeneous disorder: It
can be broadly divided into hyperadrenergic or neuropathic phe-
notypes (see Table 3 Overview of Postural Tachycardia Syndrome
phenotypes, adapted from Benarroch (2012). However, hypo-
volemia, abnormalities of the noradrenaline transporter (Esler
et al., 2006; Lambert et al., 2008; Bayles et al., 2012), infection
(Schondorf and Low, 1993), deconditioning (Parsaik et al., 2012),
and poor orthostatic cerebral autoregulation (Ocon et al., 2009)
are also implicated in Postural Tachycardia Syndrome pathophysi-
ology. Postural Tachycardia Syndrome patients frequently present
with other concurrent or comorbid autonomic symptoms. These
include pre-syncope, syncope, dizziness, palpations, headache,
fatigue, bladder, and gastrointestinal (GI) symptoms. As pre-
viously noted, around 90% of Postural Tachycardia Syndrome
patients also have joint hypermobility. In these, a mechanism
is hypothesized wherein collagen-related abnormalities in vas-
cular elasticity and compliance can lead to peripheral vascular
pooling which in turn exacerbates orthostatic intolerance related
symptoms (Benarroch, 2012; Mathias et al., 2012).
Association with psychiatric disorders
At the population level, very similar patterns are observed in
the relationship between Postural Tachycardia Syndrome or Joint
Hypermobility with anxiety disorders, particularly panic disor-
der (Bulbena et al., 2004c). For example in both, anxiety is
significantly more common in young females (Martin-Santos
et al., 1998). The combination of Postural Tachycardia Syndrome
and syncope is very strongly associated with anxiety symptoms,
(Linzer et al., 1991; Kapoor et al., 1995; Ventura et al., 2001;
Kouakam et al., 2002). Moreover, reported day-to-day func-
tional disability in Postural Tachycardia Syndrome patients is
closely related to catastrophising thoughts, somatic hypervigi-
lance and ultimately anxiety disorders and symptoms (Benrud-
Larson et al., 2003; Raj, 2006; Masuki et al., 2007; Raj et al., 2009).
Accompanying mood changes also enhance a phenomenological
overlap with generalized anxiety disorder (Khurana, 2006; Raj,
Table 3 | Postural Tachycardia subtypes.
Mechanism of Postural Tachycardia
Syndrome subtype
Markers Examples
Neuropathic Postural Tachycardia
Syndrome: Impaired sympathetically
mediated vasoconstriction in the lower
limbs
Impaired distal sweating, blunted late phase ii in Valsalva
maneuver, low supine blood pressure, reduced NA spillover
in leg veins, reduced cardiac meta-iodobenzylguanidine
uptake, High leg blood flow
Restricted postviral or autoimmune
neuropathies
Hyperadrenergic Postural Tachycardia
Syndrome: exaggerated cardiac
sympathoexcitatory responses
Standing plasma NA ≥600 pg/mL, fluctuating blood
pressure or hypertension during head up tilt
Anxiety, Pheochromocytoma, Mast
cell activation disorders, voltage-gated
potassium channel autoimmunity
Volume dysregulation Elevated plasma angiotensin II, Impairment of
renin-angiotensin-aldosterone system, impaired renal
control of fluid secretion
Conditions associated with
hypovolemia
Physical deconditioning VO2max ≤ 85% on exercise testing, reduced left ventricular
mass
Prolonged bed rest, Chronic fatigue
syndrome
Overview of Postural Tachycardia Syndrome phenotypes, adapted from Benarroch (2012).
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2006; Mathias et al., 2012). Recent data suggests patients with
POTS commonly present with symptoms of depression, elevated
anxiety and increased anxiety sensitivity, particularly with regards
to cardiac symptoms, and have a poorer health related quality of
life in both the physical and mental health domains (Anderson
et al., 2014).
Despite these data, one small American study of 21 Postural
Tachycardia Syndrome patients and 18 controls failed to find
increased prevalence of major depression or anxiety disorders in
this small patient sample. However, the patients scored signifi-
cantly higher on inattention and ADHD subscales than control
subjects (Raj, 2006), arguable representing an impaired capacity
to regulate emotions.
Although Postural Tachycardia Syndrome shares with anxi-
ety and panic disorder many psychological (e.g., tremulousness,
health anxiety, impaired concentration) and co-existing phys-
iological (e.g., palpitations, tachycardia, chest pain, dyspnea)
(Esler et al., 2004) symptomatology, a differentiating factor is
that Postural Tachycardia Syndrome can be provoked by ortho-
static challenges alone (Khurana and Setty, 1996; Khurana, 2006;
Masuki et al., 2007).
Postural Tachycardia Syndrome patients’ attentional and recall
abilities are significantly poorer than controls, (see Anderson
et al., 2014): Patients report symptoms that commonly occur
in attention deficit hyperactivity disorder (ADHD), (Raj et al.,
2009). Such associations may be due to shared abnormalities in
the norepinephrine transporter. One feature is that inattention
decreases with illness duration, likely due to adaptive or treatment
responses. Importantly, as distinct fromADHD, hyperactive traits
are absent in childhood.
Poor quality sleep, daytime sleepiness and fatigue have also
been found to impair Postural Tachycardia Syndrome patients
quality of life (Bagai et al., 2011). In Postural Tachycardia
Syndrome patients with comorbid chronic fatigue syndrome,
working memory, accuracy and information processing are
impaired during orthostasis, yet the cause of this “brain fog” that
is commonly reported in many Postural Tachycardia Syndrome
patients, remains elusive, despite investigations into cerebral
blood velocity, sleep quality or neurotransmitter function (Ocon,
2013; Ross et al., 2013). Recent evidence may provide further
insight into this given the findings that patients with POTS per-
formed worse in tests of current intellectual functioning (verbal
and non-verbal IQ) and in measures of focused attention (dig-
its forward) and short term memory (digits back). The test
results were influenced largely by years of education and the
underlying level of depression and anxiety (Anderson et al.,
2014).
Evidence of brain-body interactions from neuroimaging
Again, neuroimaging data in the field of Postural Tachycardia
Syndrome is sparse. One study has examined twelve patients
with Postural Tachycardia Syndrome and twelve matched controls
(Umeda et al., 2009). Half the Postural Tachycardia Syndrome
patients had joint hypermobility. Using functional imaging they
examined the processing of emotional and neutral pictures.
Physiologically, Postural Tachycardia Syndrome patients show
exaggerated orientating responses compared to controls. Controls
increase their heart rate when processing the visual stimuli by
about 1.5 beats per minute peaking around 2–3 s after presen-
tation. Postural Tachycardia Syndrome patients had a higher
resting heart rate (76 compared to 65 beats per minute), yet
showed an increase in heart rate to the pictures of 4–5 beats per
minute, peaking around 4–5 s after stimulus onset. The orientat-
ing response in Postural Tachycardia Syndrome patients also did
not show the same degree of sensitivity to the emotional con-
tent of the pictures observed in controls. This group difference
was also reflected in differences in regional brain responses to
the pictures (Figure 3). The deactivation of ventromedial pre-
frontal cortex, typically reflecting engagement during processing
of external stimuli (and also implicated in “antisympathetic”
autonomic control) was accentuated in Postural Tachycardia
Syndrome patients irrespective of which emotion or neutral stim-
ulus was presented. Also across both groups a region of the
basal ganglia (globus pallidus) predicted state anxiety scores. In
Postural Tachycardia Syndrome patients, connectivity between
basal ganglia, orbital and dorsolateral prefrontal cortices reflected
the interaction of anxiety state and physiological responsivity.
FIGURE 3 | Functional differences in brain of patients with postural
orthostatic tachycardia syndrome (Postural Tachycardia Syndrome)
(Umeda et al., 2009). (A) Differences between controls and Postural
Tachycardia Syndrome patients in resting heart rate and evoked responses
to neutral and emotional stimuli, characterized by accentuated prolonged
cardiac acceleration in orienting response with lack of emotion specificity.
(B) Differences in regional brain activity between Postural Tachycardia
Syndrome and control participants showing exaggerated withdrawal of
activity within ventromedial prefrontal cortex in Postural Tachycardia
Syndrome patients when encountering emotional or neutral stimuli.
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Conclusions
These findings endorse the proposal that Postural Tachycardia
Syndrome patients are constitutionally vulnerable to anxiety
symptoms through abnormalities in central mechanisms con-
trolling autonomic reactions. Postural Tachycardia Syndrome
patients showed generalized stimulus-evoked cardiovascular
responses and did not show the distinct differences across emo-
tion categories that was observed in controls (cardiac acceleration
to anger and blunted cardiac response to disgust stimuli) and
reported in previous studies (Ekman et al., 1983; Critchley, 2005).
Thus, the exaggerated cardiovascular response observed in the
Postural Tachycardia Syndrome patients abolishes the emotion-
specificity of the psycho-physiological reactions. Overall these
findings suggest that hyper-reactive bodily states can underlie
the disruption of emotional state through attenuation of activ-
ity within VMPFC. The study of Umeda et al. (2009) improves
understanding of why the expression of Postural Tachycardia
Syndrome may increase vulnerability to panic anxiety and stress-
sensitive psychosomatic disorders. These findings can help inform
treatment strategies for the mitigation of mood and other symp-
toms in some Postural Tachycardia Syndrome, endorsing the view
that approaches to correct sympathetic/parasympathetic balance
(e.g., through exercise, Joyner and Masuki, 2008) or pharma-
cotherapy (e.g., beta-adrenoceptor blockade) to diminish the
magnitude of cardio-accelerative responses (Esler et al., 2006) will
impact on negative affective experience.
VASOVAGAL SYNCOPE
Clinical descrpition and dysautonomia
Orthostasis should normally provoke an intricate integration
of central and peripheral physiological feedback mechanisms
to ensure maintained cerebral perfusion. Specifically, cerebral
perfusion is dependent on arterial pressure, systemic vascular
resistance, cardiac output, metabolic control and cerebrovascular
resistance with intrinsic autoregulation. Unfortunately, neurovas-
cular coupling allows for potential breakdown in this vital pro-
cess. An identifiable clinical condition, such as autonomic failure,
atrial fibrillation or ventricular arrhythmia, may cause syncope
but when caused by vasodilatation and bradycardia, this type
of syncope is defined as vasovagal syncope, the major form of
autonomic mediated syncope (AMS).
Cerebral hypoperfusion resulting in transient loss of
consciousness can be induced by a variety of physiological—or
in some cases of vasovagal syncope, psychological–phenomena
that lead to either inadequate cerebral perfusion pressure or
abnormally high cerebral vascular resistance. Causes of syncope
are heterogeneous but can be classified into three categories: Low
arterial blood pressure; Increased resistance to cerebral blood
flow; and other causes of cerebral dysfunction (see Table 4).
The term “vasovagal” derives from the simultaneous vasodi-
latation and vagally-mediated bradycardia leading to hypoten-
sion and resultant transient loss in consciousness, and “syncope”
descends from the Greek word, “syncoptein,” meaning to inter-
rupt or cut short (Grubb and Karas, 1999). In 1932, Sir Thomas
Lewis introduced the term “vasovagal attack”(Lewis, 1932) but
“vasoregulatory asthenia” and “neurocirculatory asthenia” were
first reported in soldiers during World War I due to poor neural
regulation of peripheral blood flow perturbing cardiac function
(Wooley, 1976). As Lewis described, vasovagal attacks are pre-
cipitated by an increase of sympathetic nerve activity– increased
vascular resistance, blood pressure and heart rate—followed by
bradycardia, vasodilation and a marked fall in arterial blood
pressure, cerebral hypoperfusion.
Vasovagal syncope is the most common form of autonomic
mediated syncope (other types include carotid and situational).
It is characterized by a sudden transient loss of consciousness
and postural tone caused by cerebral hypoperfusion provoked
by physiological or emotional stressors. The term “vasovagal”
derives from sympathetic vasoconstrictor withdrawal caus-
ing vasodilatation and increased vagal nerve activity causing
bradycardia, these leading to hypotension and resultant loss of
consciousness. vasovagal syncope accounts for around 40% of
syncopal events, making it the most common cause of syncope
(Fenton et al., 2000). It affects 15% of children under 18 years
(Lewis and Dhala, 1999) while 35% of adults aged 35–60 expe-
rience a syncopal episode (Ganzeboom et al., 2006). Syncope
accounts for 3–5% of emergency room admissions and evalua-
tion of syncope cases accounts for 1–6% of hospital admissions
(Kapoor et al., 1995), with a 35% chance of a recurrent episode
(Savage et al., 1985). Fainting is typically triggered by social
/emotional stress, often in the context of physical factors such
as higher ambient temperature, prolonged standing, and body
boundary violation (blood/injury) phobia. There may be a
familial history of syncope (Mathias et al., 1998) and more than
80% of individuals will have their first episode before age 20
years. While benign, risks include injury from falling and hypoxic
seizure due to hypotension.
Associations with psychiatric disorder
Psychiatry, neurology and cardiology research groups have found
psychiatric conditions are over-represented in patients with vaso-
vagal syncope, particularly anxiety, depression and somatization
disorders (Giada et al., 2005). In psychiatry, a survey of 67 patients
(Leftheriotis et al., 2008) identified 58% as showing a vasovagal
episode during head up tilt and 45% had a history of syncope.
Interestingly, vasovagal syncope patients who do not respond
to treatment are more anxious on rat and depressed (on rating
scales) than normal vasovagal syncope treatment responders and
also report more negative thoughts regarding threats to physical
harm or death as well as higher levels of avoidance/protection
coping and rumination (Gracie et al., 2006).
Compared to non-fainting controls people with vasovagal
syncope have higher rates of anxiety (30%) panic (20%), and
depression (15%) and higher anxiety scores (Cohen et al., 2000;
Kouakam et al., 2002). Recent work in women finds higher lev-
els of anxiety in women with vasovagal syncope and controls
with transient loss of consciousness compared to controls without
(Zysko et al., 2014) Blood/injury phobia is common in vasova-
gal syncope (Luborsky et al., 1973; Sledge, 1978; Cohen et al.,
2000; McGrady et al., 2001), with syncopal episodes often pro-
ceeding anticipation of real or fantasized physical harm in a
social context, where fight/flight was perceived as unacceptable,
i.e., “. . .when an individual experiences fear he must deny”(Engel,
1962). Depression, anxiety, frustration and helplessness are also
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Table 4 | Classification and causes of syncope.
Low arterial blood pressure Increased resistance to cerebral
blood flow
Other causes of cerebral dysfunction
Low cardiac output Cerebral vasoconstriction Epilepsy may be confused with simple
faints
Inadequate venous return due to excessive venous pooling
or low blood volume
Low Paco2, due to hyperventilation Metabolic and endocrine
disorders—hypoglycaemia, Addison’s
disease, hypopituitarism
Cardiac causes—tachyarrhythmias, bradyarrhythmias,
valvular disease, bradycardia
Cerebral vasospasm Electrolyte disorders—may be associated
with hypovolaemia or predispose to
cardiac arrhythmias
Low total peripheral vascular resistance Vascular disease—either extracranial
of intracranial areteries
Vasovagal attacks
Widespread cutaneous vasodilatation in thermal stress
Reflex causes—vasovagal attacks, “carotid sinus
syndrome,” visceral pain reflexes (may cause vasodilatation
or vasoconstriction), decreased stimulation of visceral
stretch receptors (e.g., voiding distended bladder)
Vasodilator drugs
Autonomic neuropathies
identified antecedents of vasovagal syncope (Luborsky et al.,
1973). Physical and psychosocial threat are a provocative factors
for the induction of vasovagal syncope. Attenuated electroder-
mal stimulus processing negativity have been recorded during
anticipation of unpleasant images in vasovagal syncope patients
(Buodo et al., 2012), suggestive of a lack of emotional anticipation
and adjustment to emotional stressors.
Faints are not only triggered by these salient emotional
challenges but are also influenced by affective factors. However,
the causal relationship between cognitive/affective style and vaso-
vagal syncope is presently a subject of close scrutiny, and there
exists a bidirectional relationship between cognitive/affective
factors and syncopal symptoms in people with vasovagal syncope
(Gracie et al., 2006).
Almost two thirds of patients referred for suspected syn-
cope present with symptoms or clinical features of Postural
Tachycardia Syndrome. Being female, under the age of 40 years,
and with peripheral venous pooling when upright are among
the diagnostic indicators. Autonomically mediated syncope and
Postural Tachycardia Syndrome that are recorded previously
(Stewart, 2009; Kanjwal et al., 2011) yet syncope occurs more
commonly in Postural Tachycardia Syndrome (Ojha et al., 2010).
Further relationships exist between autonomic physiological
parameters and the occurrence of fainting in people vulnera-
ble to vasovagal syncope. In patients with vasovagal syncope,
Low Frequency Heart Rate Variaibility is significantly negatively
correlated with fainting frequency [r = −0.56, p = 0.018] and
log [fainting frequency] [F = 12.64, p = 0.003, R2 = 0.46] in
contrast, High Frequency Heart Rate Variability (predominately
parasympathetic) was significantly positively correlated with
fainting frequency [r = −0.54, p = 0.026] and log[fainting fre-
quency] [F = 10.96, p = 0.005, R2 = 0.42] (Beacher et al., 2009).
Evidence of brain-body interactions from neuroimaging
Using neuroimaging, Beacher et al tested for differences in brain
structure between people that faint and those that do not, to
understand more about the mechanisms governing underlying
patterns of psychophysiological response and associated psycho-
logical vulnerabilities (Beacher et al., 2009). Using structural
scans of healthy individuals with and without vasovagal syncope,
they compared regional gray and white matter volumes across the
whole brain, with special attention to brain stem regions (where
neurodegeneration is associated with syncope in conditions like
Mulltiple System Atrophy). They observed significant differences
in regional volume (relative reduction in people with a history
of fainting) within medulla and midbrain encompassing parts of
the nucleus of the solitary tract (NTS) and ventral periaqueduc-
tal gray matter (vPAG) (Figure 4A). The bidirectional pathways
between the PAG and the amygdala has been examined in ani-
mal studies of orienting and defense responses, with stimulation
of the ventrolateral PAG (vlPAG) inducing passivity and down-
regulation of sympathetic cardiovascular activity (Porges, 2003).
Symbiotic autonomic changes, such as cardiovascular or sudomo-
tor fluctuations accompany these behavioral modifications. Their
findings were significant at the group level, but had less than 70%
specificity and sensitivity; nevertheless they suggest that brain-
stem structure may be a context for vasovagal vulnerability. They
also looked within the group as to the correlation with fainting
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FIGURE 4 | Vasovagal syncope: Associations with brain structure
(Beacher et al., 2009). (A) Significant group differences in medulla and
midbrain volumes between healthy people with and without history of
fainting, with reduced volume associated with vasovagal syncope. (B)
Correlation of volume within left caudate nucleus in people with history of
fainting. Reduced gray matter volume in contiguous regions correlated with
increased anxiety score (red), increased fainting frequency (yellow) and
increased high frequency heart rate variability (HF-heart rateV) (green).
frequency (this was in fact quite low across the group, a mean of
0.12 faints per year). Gray matter volume within the left caudate
nucleus correlated with individual differences in lifetime number
of fainting episodes. Interestingly, adjacent caudate regions corre-
lated with anxiety scores and high frequency heart rate variability
of these same individuals (Figure 4B).
Conclusions
Together these last observations suggest that interaction between
emotional and physiological state at the level of caudate nucleus
influence the likelihood of fainting predisposed to by differ-
ences in brainstem structural organization. These observations
are noteworthy since an association is also demonstrated between
high frequency or “vagal” regulation of the heart (HF-heart
rateV) and frequency of syncope in vasovagal syncope partici-
pants. Moreover, emotional state, notably anxiety, is well recog-
nized as a predisposing factor to syncope in vulnerable vasovagal
syncope individuals (association was observed with the occur-
rence of fainting across all participants as a whole) and influences
cardiovascular autonomic regulation (Friedman et al., 1993).
Therefore, their interpretation of the findings is that predispo-
sition to vasovagal syncope relates to differences in functional
neuroarchitecture (expressed as differences in structural mor-
phology) of brainstem regions mediating cardiovascular home-
ostasis, including baroreflex regulation of blood pressure. Further,
their findings suggest that the likelihood of recurrent fainting is
influenced at the level of left caudate nucleus, regions of which
we found to be more strongly coupled to autonomic cardiac reg-
ulation in individuals with vasovagal syncope than in controls,
and which interact with adjacent regions, also within the caudate,
which contribute to the expression of anxiety.
ADDITIONAL PHENOTYPES
Idiopathic hyperhidrosis
When the amount of excreted sweat exceeds that required to
normalize body temperature and causes significant functional
impairment, this is called “Idiopathic Hyperhidrosis.” The etiol-
ogy of Idiopathic Hyperhidrosis remains unknown but the condi-
tion is defined by excessive local or generalized sweating, typically
on the palms of the hands, soles of feet and axillary. Eccrine
glands are primarily implicated in Idiopathic Hyperhidrosis, with
the exception of axillary Idiopathic Hyperhidrosis which appears
to have diffuse pathophysiology (Bovell et al., 2001; Lonsdale-
Eccles et al., 2003). There can be a number of causes of secondary
hyperhidrosis (see Table 1) and once these have been elimi-
nated, sudomotor activity can be examined with indicator dyes
that change color on exposure to moisture whilst the patient’s
body temperature is raised in a thermoregulatory sweat test (Low
and Fealey, 2002). Idiopathic Hyperhidrosis can be provoked by
everyday factors, such asmild exertion or food ingestion. Updated
refs in 5th edition AF chapters.
Idiopathic hyperhidrosis patients commonly report anxiety
(Karaca et al., 2007; Beacher et al., 2009), though it remains
unclear whether anxiety is a prodromal symptom of IH or
vice versa (Noppen et al., 1997). Explanations of Idiopathic
Hyperhidrosis as basal sympathetic hyperactivity are complicated
by most patients’ accompanying affective distress and heart rate
variability findings of increased parasympathetic heart rate vari-
ability (Birner et al., 2000; Kaya et al., 2005). In a study by De
Marinis and co-workers (Kaya et al., 2005), 34% of Idiopathic
hyperhidrosis patients also had orthostatic hypotension, further-
more, this sub-group had greater total body sweat rates and
larger orthostatic blood pressure and heart rate changes than the
remaining Idiopathic Hyperhidrosis patients and normal con-
trols. However, in consideration of the subjects’ age range (28 ± 6
years); these were more likely to be vasovagal episodes rather than
autonomic failure-induced hypotensive episodes.
Surgical interventions for Idiopathic Hyperhidrosis typically
involve thoracic sympathectomy, which often causes compen-
satory sweating yet still apparently improves psychosocial distress
(Ramos et al., 2006). Such convoluted findings make delineat-
ing emotional and sudomotor factors in Idiopathic Hyperhidrosis
challenging.
Depersonalization disorder
Depersonalization disorder is a dissociative disorder, defined by
symptoms that include feelings of derealization (one’s surround-
ings feel unreal), emotional numbing, feelings of disembodiment
and memory recall deficits relating to the personalization but not
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retrieval of memory (Lee et al., 2012). Depersonalization is a dis-
engaging defense response to overwhelming threat (Lee et al.,
2012), with a lifetime prevalence of 74% for mild episodes and
1–2% for chronic Depersonalization disorder (Sierra and David,
2011).
Despite significantly elevated levels of anxiety in depersonal-
ization disorder (Sierra et al., 2012), subjects have consistently
recorded attenuated sympathetic responses to emotional aver-
sion. Lader andWing (1966) recorded the results of two panic dis-
order patients who became depersonalized during skin conduc-
tance recording. In their anxious or panicked state, the patients
displayed low skin resistance but during episodes of deperson-
alization, both recorded a lack of skin conductance fluctuations
and significant increases in skin resistance. Compared to “agitated
depressed, non-agitated depressed, schizophrenic, phobic, obses-
sive compulsive disorder, personality disorder, hysteria” patients
and normal controls, depersonalization disorder patients had the
lowest baseline measure of forearm blood flow of all the groups
(Kelly and Walter, 1968).
Electrodermal responses have predominantly been used as
a peripheral measure of autonomic arousal in depersonaliza-
tion Simultaneous recording of electrodermal responses (sym-
pathetic drive to skin) with functional neuroimaging, finds that
depersonalization disorder patients produce decreased hypotha-
lamic and amygdala blood oxygen level dependent (BOLD)
responses during presentation of happy and sad expressions
respectively (Lemche et al., 2007, 2008). These findings were
reversed in healthy controls. Electrodermal responses are both
more quickly manifested and yet abnormally weakened in
Depersonalization disorder participants during aversive stimuli
exposure (Sierra et al., 2002), indicating hypervigilant atten-
tional appraisal and rapid suppression of physiological emo-
tional arousal. Norepinephrine levels have also been found to
be negatively correlated with Depersonalization disorder severity
(Simeon et al., 2003).
Depersonalization disorder patients share anecdotal
symptoms with patients with corticolimbic disconnections
(Mayer-Gross, 1935), supporting the hypothesis that, in
Depersonalization disorder, emotional manifestation and allo-
cation has become out-of-step with the processes required for
emotional embodiment. Models of Depersonalization disor-
der, posit environmental and emotional hypervigilance and
subsequent emotional attenuation during emotional aversion,
evidenced by reduced electrodermal responses to disagreeable
images compared to both healthy controls and anxiety disorder
patients, despite the Depersonalization disorder subjects being
equally as anxious as the anxiety participants (Sierra et al.,
2002).
In Depersonalization disorder, inverse correlations between
right ventral PFC BOLD activity and left insular BOLD responses
during aversive emotional stimuli have been reported (Phillips
et al., 2001), and between happy and sad expression intensity
and right hypothalamus and right amygdala BOLD responses
respectively have been recorded. Moreover, negative correlations
between SCRs and dorsal PFC BOLD responses have also been
described in Depersonalization disorder (Lemche et al., 2007,
2008).
CONCLUSIONS
Together these data argue for the recognition of neurovisceral
phenotypes that underlie constitutional predisposition to affec-
tive symptoms and that reflect the interaction and emergence
of affective feelings with representations and control of bodily
arousal. There is circumstantial evidence for a genetic basis to
some neurovisceral phenotypes, such as in relation to certain
collagen disorders. Neuroimaging techniques, particularly when
combined with physiological measurement, have the potential to
dissect brain mechanisms mediating the interplay between phys-
iological control and psychological response to emotion. Data in
neurovisceral phenotype models implicate a discrete set of brain
regions that include the amygdala, cingulate and insula cortex
along with specific levels of the brainstem, basal ganglia and ven-
tromedial prefrontal cortex. Further work is needed to extend
what is already known regarding the distinct and overlapping
contribution of these regions to subjective feelings of anxiety,
perception and misperception of bodily arousal, generation of
stereotyped patterns of affective reactions (faints, tachycardia,
sweating and hyperventilation). A detailed understanding of these
processes in clinical and non-clinical groups, alongside greater
clinical recognition of neurovisceral phenotypes and their expres-
sion across neuropsychiatric disorders, will inform the innovative
development of pharmacological and biobehavioral interventions
for the management of psychosomatic symptoms, panic and
anxiety states.
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